Corrigendum to “Argentinean recommendations on the identification of treatment failure in relapsing remitting multiple sclerosis patients” [J. Neurol. Sci. 385C (2018) 217–224]

The authors regret that they did not include the following conflict of interest statement: “Dr. Marcela Fiol (MF) has received reimbursement fordeveloping educational presentations from Merck-SeronoArgentina, Biogen-IdecArgentina, Genzyme Argentina, Bayer Inc and Novartis and travel/accommodations from Merck-SeronoArgentina, Bayer Inc., Novartis and TEVA-TuteurArgentina.”

Source: Journal of the Neurological Sciences - February 12, 2018 Category: Neurology Authors: Edgardo Cristiano, Ricardo Alonso, Amelia Alvez Pinheiro, Elizabeth A. Bacile, Mar ía Eugenia Balbuena, Carlos Ballario, Andrés G. Barboza, Santiago Bestoso, Marcos Burgos, Fernando Cáceres, Edgar Carnero Contentti, Adriana Carrá, Ernesto Crespo, Mar� Tags: Corrigendum Source Type: research